Standout Papers

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease 2011 2026 2016 2021 769
  1. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease (2013)
    Dick de Zeeuw, Tadao Akizawa et al. New England Journal of Medicine
  2. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes (2011)
    Pablo E. Pérgola, Philip Raskin et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 76 standout
Sub-graph 1 of 19

Citing Papers

Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
19 intermediate papers

Works of Melissa Krauth being referenced

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013 Standout
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
2011 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Melissa Krauth 590 117 174 937 357 8 1.8k
Stacey Ruiz 459 91 137 925 213 12 1.7k
Hitomi Usui 645 124 170 438 359 14 1.6k
Bieke F. Schrijvers 639 75 149 490 296 18 1.5k
Ae Seo Deok Park 1062 40 104 1058 189 8 2.3k
Yoshisuke Haruna 543 87 259 436 214 23 1.6k
Michele T. Rooney 730 101 190 516 677 17 2.0k
B. D. Myers 1227 99 279 485 210 16 2.0k
Mark T. Houser 629 70 210 505 273 31 1.6k
Eric Grossman 306 74 85 556 317 16 1.5k
Paul L. Miller 821 54 112 665 202 16 1.7k

All Works

Loading papers...

Rankless by CCL
2026